Kromek Share Discussion Threads

[aqc888] 23/9/2021 08:13:07

Especially when you consider these figures take no account of potential sales of the biological pathogen detector

[aqc888] 23/9/2021 08:10:09

Given Kromek already have revenue making up 75% of analysts forecasts for the year and they have another 6 months to make up the rest, I wouldn’t see this extra ‘upto’ figure of £585k for the year as a negative sign for Kromeks revenue for the year as you make out

[aqc888] 23/9/2021 08:02:07

“With global defence and security spend on the rise around the world in response to volatile international relations, we expect to receive further orders for our nuclear security products, contributing to our significant anticipated revenue growth for this year and our pipeline for the years ahead.”

[quepassa] 23/9/2021 07:56:08

It's another "UP TO" contract.


up to $1.6m = £1.17m

or annualised

UP TO £585,000 p.a. over 2 years.


who can say/know/guess what the realistically likely amounts are when an "up to" figure is given?

wouldn't it be better if they said what the initial concrete size of the contract was with possibility of increasing up to x?


ALL IMO. DYOR.
QP

[b00mb0y] 23/9/2021 07:37:16

Can we expect a drop in the share price then on that news?

[dougmachin] 23/9/2021 07:26:31

Some news...

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, announces that it has received a contract worth up to $1.6m from a US federal entity for the Group's D3S-ID wearable nuclear radiation detector that is designed to enable first responders, armed forces, border security and other CBRN experts detect radiological threats. The contract will be delivered over two years commencing immediately.

[quepassa] 22/9/2021 19:08:30

Watch the Smiths video.


hXXps://www.smithsdetection.com/products/bioflash-biological-identifier/

Rapid / live results


ALL IMO. DYOR.
QP

[aqc888] 22/9/2021 18:17:17

Quepassa, according to Hill at Equity Development the global market for the covid biological pathogen detector is estimated at £500m with Kromek gaining 20% on 52% profit from memory, (sales of the wider spectrum pathogen detector aren’t included in this). The smiths detector from what I remember needs collected samples to be sent to a lab?.. The Kromek detector has also mopped up around £10m in funding from the U.K. and US governments to develop the machine (not shareholders cash). The current valuation of Kromek does not include any potential sales of either of the biological pathogen detectors.

[quepassa] 22/9/2021 15:25:13

Smiths Detection.

Part of the mighty, global Smiths Group.



BioFlash Biological Identifier - Mobile high sensitivity biothreat detector


hXXps://www.smithsdetection.com/products/bioflash-biological-identifier/

1. WATCH THE VIDEO
2. Read the Brochure



Isn't this piece of kit from Smiths Detection an airborne pathogen detector??


ALL IMO. DYOR.
QP

[33mick] 21/9/2021 14:11:18

Not that I'm aware of Simithy I've researched all the bio/Patho airborne competition and as far as I know Philips have no product or news in this area.
But they could in the future who knows.
There are recognised Militarily grade detection companies that are in the area, all using filter cassette collection and send to lab or trigger and lab confirmation.
Flir, Smith's, Northrop Grumman + others...but Kromek's design is unique in its use of a special highly accurate UK RNA sequencing platform.
Please correct me if I'm wrong about Philips ...it would only take seconds to add a link yes

[simithy] 21/9/2021 13:49:23

I think Philips have/had a stake in this game? IMO

[simithy] 21/9/2021 13:49:23

I think Philips have/had a stake in this game? IMO

[33mick] 21/9/2021 12:12:42

The US defence spec has changed a few times over the years, but the listed design spec below is as far as I can see the exact functional spec of Kromek s just displayed KAP scan full spectrum DARPA design.

BD21 Biosensor Redesign: DHS Seeks Contractors to Improve Urban BioThreat Classification Sensor
by Global Biodefense Staff

September 3, 2021

"The Department of Homeland Security CWMD Research & Development division is seeking information from contractors capable of supporting its requirements for the development of more affordable aerosol biosensors that operate and alert in real time and are capable of detecting and characterizing or identifying biological agents in operational environments"

"The DHS CWMD office intends to deploy biosensors in both indoor and outdoor urban environments to conduct real-time monitoring of biological threats and seeks industry to continue research and development efforts in order to meet characterization and cost goals. The redesign of the commercially available biosensors is being proposed to occur over 15 months and will take place in 2 phases, to include: the design of at least 2 prototypes that will be tested by the performer followed by an opportunity for a prototype redesign before delivering the final prototypes to the government for an independent operational background test and chamber test."

Minimum requirements for the sensors include:

Capable of accurately detecting and classifying Category A and B biological agents in environmental aerosols with varying levels of background particles.

Capable of continuous monitoring of aerosols.

Capable of sending alerts to an operator after detection, characterization and/or preliminary identification within a maximum time of 30 minutes.

Ability to differentiate between biological and non-biological particles while rejecting benign particles that are common interferents such as brake dust and diesel smoke.

Sensors must be capable of classification of biological particles to a Kingdom level at minimum (bacteria, virus, toxin, spore).

Sensor differentiation of particles should reduce false alarms in urban operational environments to a level of < 3 alarms/day.

Sensors must be capable of detecting down to a 1um particle size at concentrations relevant to a 3kg (threshold), 0.5kg (objective) times aerosolized release based on biological particle type.

[aqc888] 20/9/2021 22:07:38

Boomboy, if you believe that Kromek have no IP regarding this detector and it’s just other companies technology why have you got 40% of your portfolio invested here? It doesn’t make much sense...

33mick has been suggesting for quite sometime that in his opinion nanopore technology was likely to be the technology Kromek are basing their detector on...

[b00mb0y] 20/9/2021 16:26:48

Hmmm, I wonder why mick33 didn’t tell us that. Let’s face it, he knows it all. After all he is the biggest paid ramper on here. Wonder what he has to say about that.

[quepassa] 20/9/2021 14:32:21

By the way, highly-regarded Oxford Nanopore Technologies finally filed seven days ago for its long awaited IPO.

The estimated market value of ONT will upon listing be circa £4 billion.

An interesting recent article about ONT's forthcoming IPO in Genetic Engineering and Biotech News

hXXps://www.genengnews.com/news/oxford-nanopore-files-for-london-ipo-with-potential-value-of-5-5b/



ALL IMO. DYOR.
QP

[quepassa] 20/9/2021 11:03:02

Covid DNA-sequencing.



What other companies are doing.



Oxford Nanopore Technologies.

MinION and other Oxford Nanopore Technologies REAL-TIME sequencing products



Reality Check 1.

hXXps://nanoporetech.com/



Reality Check 2.

hXXps://nanoporetech.com/about-us/news/oxford-nanopore-launches-midnight-kit-suitable-low-high-throughput-sars-cov-2




ALL IMO. DYOR.
QP

[dexter1612] 18/9/2021 21:08:39

Interesting Mick, thanks for posting.

[33mick] 18/9/2021 16:27:22

Talking internationally a sobering read from Germany.

Winter Worries: The Changing Virus - DER SPIEGEL

The Changing Virus
As winter approaches, experts are concerned that more contagious variants of the coronavirus could emerge. Measure to prevent the spread of the virus, they say, will be with us for a long time to come.

[aqc888] 17/9/2021 17:24:24

There was an interview with the ceo where he spoke of ‘serious discussions with various interested governments’. I think other countries where covid rates are being kept low will be far more interested in this detector than the U.K. I should think in the U.K. the market will be restricted to vulnerable people in the nhs and care homes and institutions where £20k won’t be seen as a big outlay - such as investment banks wanting to reassure staff to return and private schools. These markets in themselves should prove quite substantial but I can see far more interest internationally.

[ark87] 17/9/2021 16:25:34

Agree. Could be used with traffic lights system at large venues/hospitals/airports/schools ect. Strong Covid detection Red light - Everyone mask up/social distancing. Green light: No Covid detected: No masks, carry on as normal.

Or they might just not bother and iwill be used by government only to monitor Covid levels. Hopefully we find out in next few months.

[petersw1] 17/9/2021 13:17:15

I'd imagine if a detection is made in a hospital you'd activate more stringent measures to prevent spread. Measures I could imagine would be to switch to higher grade face masks and PPE, take more care to avoid cross contamination and test everyone. You could also re-direct particularly vulnerable patients elsewhere.

[dogwalker] 17/9/2021 12:52:53

Thanks a lot Nick4212.

[nick2412] 17/9/2021 12:16:50

Dogwalker, that's a key question and it's why I think the broader bio-threat detector will be the product that sells significantly and be a commercial success rather than the Covid specific detector.The latter should be available before the broader one marketed for defense budgets and referenced as commercially available during this financial year.

I did ask the question the question you raise at the AGM - I've copied it here (below) and the answer from Kromek. The reply didn't really shed much light aside from saying it depends on the concentration. I can see why it would be useful for cruise ships or isolated long-term 'events' where detection can be followed up by mass testing.

I'm not sure, however, that sports events, shopping centres etc will want results that say 'we detect Covid but aren't going to do any follow up actions.' There would be a clamour for shutdowns and cancellations and that's not what these businesses will want. Schools? If closures are not a desired option then the same applies. The price of 20k is an issue as well.

I think the focus will be on vaccinations, booster jabs etc. As long as the NHS isn't over-run then the emphasis is going to be on testing individuals rather than a broad signal that Covid is evident in a 50,000 crowd. The defense sector, however, is different of course and will have both the budget and a compelling need.


Question:- For the Covid and other health threat virus detector, what use is it in an area of a very large number of people such as a stadium or airport given it doesn’t identify who has the virus and should therefore isolate immediately? In other words what helpful actions does the detector prompt when signalling virus detection for the purchaser of the product?

Answer: We are conducting a range of trials and pilots in locations with differing footfall densities and are working with those organisations to build and develop appropriate use-case models appropriate for the particular location. The actions that will be taken by the user will vary depending on the use-case developed and the concentration of Covid or other pathogens present and identified by the technology.